Drug profile · INN
siponimod
MAYZENT
- US status
- approved
- Patents linked
- 1
- News articles
- 0
Quick answer
siponimod (MAYZENT) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN siponimod
Brand MAYZENT
Route ORAL
Formulation TABLET
ATC code L04
Related patents
Search patents →Frequently asked questions
What is siponimod?
siponimod (MAYZENT) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for siponimod?
MAYZENT is a marketed brand name for siponimod. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of siponimod?
siponimod has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.